• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Philips Launches Its Smallest Portable Nebulizer in North America

by Fred Pennic 10/29/2018 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Philips Launches Its Smallest Portable Nebulizer in North America

Today, Philips launched InnoSpire Go, its smallest and lightest portable hand-held nebulizer. This innovative technology not only provides portable, fast and effective medication delivery but is also proven to reduce treatment time by up to 25 percent.  The easy-to-use and virtually silent InnoSpire Go puts hospital-grade nebulizer technology into the hands of the user for portable, fast and effective medication delivery. InnoSpire Go is available in the United States and additional countries including Australia, Denmark, Finland, Germany, Norway, and the United Kingdom. 

Across the world, over half a billion people suffer from chronic respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD). Although both of these diseases are incurable, symptoms can be managed with the proper treatment, which often includes nebulizers. Technology like InnoSpire Go transforms medication into ultra-fine droplets so they can penetrate the lungs effectively and efficiently – providing a new level of ease to patients with respiratory diseases. With a built-in, rechargeable battery that provides up to 30 treatments per charge and simple two-part assembly, InnoSpire Go can be used at home or on the go.

Globally, more than 252 million people suffer from asthma and another 251 million from chronic obstructive pulmonary disease (COPD). [2, 3] Though incurable, asthma and COPD can be made more manageable with the correct therapy, such as nebulized medications. The InnoSpire Go transforms needed medication into ultra-fine droplets so that they can penetrate even the smallest structures of the lungs effectively. With a built-in, rechargeable battery that provides up to 30 treatments per charge and simple two-part assembly, the InnoSpire Go can be used at home or on the go.

“We want to provide patients with respiratory diseases with a means of effective and rapid therapy,” said Linda Trevenen, Business Leader, Respiratory Drug Delivery at Philips. “InnoSpire Go daily inhalation therapy is as easy as brushing your teeth. Thanks to this nebulizer’s light weight, ease of use, and fast, four-minute treatment time, it is ready for use anywhere, anytime, and is particularly suitable for children and individuals who want to maintain an active lifestyle.”

The clinically proven vibrating mesh technology inside InnoSpire Go, turns liquid medication into a fine mist, for fast treatment in four minutes with less wasted medication and no replaceable batteries. [4] Philips InnoSpire Go can be used with commonly prescribed drugs for respiratory disease. Aerosol performance is maintained over the life of the product and is delivered with audible and visible indicators that signal therapy completion. The easily detachable mouthpiece makes the InnoSpire Go easy to clean and maintain.  Each InnoSpire Go includes our Lite Touch mask for optimal comfort.

References

1] 2.5 ml Salbutamol, 25 percent reduction versus predecessor Aeroneb Go

[2] Global Burden of Disease Study, World Health Organization 2016

[3] Global Asthma Network. 2014. Retrieved from: http://www.globalasthmareport.org

[4] 2.5 ml Salbutamol, less wasted medication than jet nebulizer technology. Typically 0.3 ml total residual volume.

 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Philips

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |